Disclaimer

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions



DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?

SJM-CV WEB-0718-0009

/content/bss/divisionalsites/livesites/reusable/cv-livesite/us/en/pages/home
30
CARDIOVASCULAR
hamburger
BACK
JETi Hydrodynamic Thrombectomy System
Features

Request a hands-on demonstration

The JETi™ Thrombectomy System is designed to remove both peripheral arterial thrombus and peripheral venous thrombus.1

The JETi™ thrombectomy device leverages cutting-edge technology to treat both peripheral arterial and venous thrombus with a novel hydrodynamic design.1 Utilizing a uniquely positioned high-pressure saline jet, JETi™ is able to fragment clot within the safety of the catheter tip1 while reducing catheter clogs.1 With HyperPulse™ Fluid Delivery, JETi™ can also sub selectively infuse/deliver diagnostics or therapeutics intra-procedurally.1

Perclose ProGlide

Dual-action Design1 Enables Efficient Clot Removal2

Unique Design1 to Rapidly Remove Thrombus Burden2

  • Novel hydrodynamic design to aspirate and fragment clot while reducing catheter clogs1
  • High single-session treatment success rate3 to help reduce costly ICU length of stay4

Minimal Risk of Procedural Complication

  • Minimized risk of embolization5,6 and hemolysis5
  • Low profile 6F and 8F catheters7 to help avoid large-bore access site complications8

Proven Performance

  • Unobstructed flow restored in 94.3% of the limbs in patients with acute iliocaval and iliofemoral venous thromboembolism3
  • Successful removal of targeted thrombus in 85% of acute and subacute lower limb ischemia cases9

References

  1. JETi™ Thrombectomy System Instructions for Use (IFU). Refer to IFU for additional information.
  2. Schubert, F. et al. Cardiovasc Intervent Radiol. 2022 Jan;45(1):112-120.
  3. Razavi et al. JVIR. 2021.
  4. Khalsa, B., et al. JVIR. 2020.
  5. Cournoyer-Rodrigue et al. JVIR. 2020 
  6. Moser, K et al. JAMA. 1994 Jan;271(3):223-225.
  7. Data on file at Abbott.
  8. Redfors, B., et al. JAMA Cardiology. 2017.
  9. Onofrey, K., et al. JVS. Volume 75, Issue 6, June 2022, Page 219.

MAT-2202239 v1.0

Request a Demo

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

YESNO
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

The following content is intended for Healthcare Professionals except for those in France. Some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.



Si vous êtes un professionnel de santé exerçant en France ou dans les territoires Français, veuillez visiter notre site en français.



Do you want to continue? 

YesNo